Publicaciones en las que colabora con JUDIT PALLARES QUIXAL (10)

2013

  1. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias

    DMM Disease Models and Mechanisms, Vol. 6, Núm. 3, pp. 710-720

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

2010

  1. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

    European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850

2009

  1. A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma

    Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226

  2. CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation

    American Journal of Pathology, Vol. 174, Núm. 1, pp. 287-296

  3. Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints

    Journal of Clinical Pathology, Vol. 62, Núm. 9, pp. 777-785

2008

  1. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

    Oncogene, Vol. 27, Núm. 18, pp. 2513-2524

  2. Loss of heterozygosity in endometrial carcinoma

    International Journal of Gynecological Pathology, Vol. 27, Núm. 3, pp. 305-317

  3. Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma

    Human Pathology, Vol. 39, Núm. 7, pp. 994-1001

  4. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

    Modern Pathology, Vol. 21, Núm. 6, pp. 691-699